[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:hepatocellular-carcinoma:hepatitis-c-infection":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Hepatocellular Carcinoma","Hepatitis C Infection",4,[8,16,23,29],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05797805","A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:11.311767Z","2026-05-05T02:43:29.284306Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05096715","Atezolizumab+Bevacizumab+SBRT in Unresectable HCC",[20],"Phase 1","2026-08-26T02:16:41.943926Z","2026-05-05T02:43:27.321203Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT04524871","A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)",[12],"2026-08-26T02:18:51.833592Z","2026-04-29T02:57:57.128598Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT05486572","Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI",[],"2026-08-26T02:15:37.042762Z","2026-05-05T02:43:29.351159Z"]